Treatment of intravenous thrombolysis with half-dose recombinant human prourokinase reduces the rate of tirofiban use during early routine catheterization period

Bibliographic Details
Main Authors:	Chao Jiang, Jie Gao, Dong-Lei Luo, Jing-Tao Guo
Format:	Article
Language:	English
Published:	Elsevier 2022-07-01
Series:	Asian Journal of Surgery
Subjects:	Recombinant human prourokinase Percutaneous coronary intervention Catheterization Tirofiban Slow flow No-reflow
Online Access:	http://www.sciencedirect.com/science/article/pii/S1015958422004006

Internet